Stocks and Investing Stocks and Investing
Fri, March 5, 2021
Thu, March 4, 2021
Wed, March 3, 2021
Tue, March 2, 2021
Mon, March 1, 2021

Kevin DeGeeter Initiated (SNSE) at Buy and Held Target at $36 on, Mar 1st, 2021


Published on 2024-10-27 15:48:15 - WOPRAI, Kevin DeGeeter
  Print publication without navigation


Kevin DeGeeter of Oppenheimer, Initiated "Sensei Biotherapeutics, Inc." (SNSE) at Buy and Held Target at $36 on, Mar 1st, 2021.

Kevin, nor any peers, have made any analyst calls on SNSE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30